ClarifiASD

The Beginning

In 2018, Quadrant Biosciences created the world’s first autism saliva test, ClarifiASD. But before they could to market, they had the tricky task of educating the general public on how it worked and why it mattered, and getting healthcare professionals excited about a new way of diagnosis.

(Click me)

The Campaign

We launched a 360 campaign targeted towards high-income parents with children between 12-48 months in the United States with the goal of driving buzz and education. Without an actual product on the market yet, our plan was to collect emails of interested buyers and upkeep regular communication until the big launch day.

At the same time, we launched a smaller-scale campaign towards prominent pediatricians and autism groups in the United States where we could educate and help spread the word on this groundbreaking technology.

(Click me)

The Execution

Over the course of 12 months, our small marketing team of four were able to…

  • Build out organic social channels on Youtube, Twitter, Facebook, and Instagram that captured thousands of followers

  • Create advertising campaigns that reached millions, with CPCs as low as $.20 and CTR’s as high as 4.5%

  • Capture half a million email leads through our online forms and conference attendees

  • Partner with some of the nation’s largest autism organizations, including Autism Speaks and ECHO Autism

  • Establish local and national news placements

  • Strategize and implement a complete SEO campaign from scratch

(Click me)

The Results

By the time ClarifiASD launched in early 2020, millions of homes understood epigenetics and the current diagnostic product better than ever before. Finally, parents had hope that there was a concrete alternative to a previously subjective test and pediatricians were excited to order kits for their own office.